Hoth Therapeutics Inc. (HOTH) Prices 1.449M Share Common Offering at $3.45/Sh

Hoth Therapeutics, Inc. (NASDAQ: HOTH) today announced the pricing of its previously announced "best efforts" underwritten public offering of 1,449,275 shares of its common stock at a price to the public of $3.45 per share. Hoth expects to receive aggregate gross proceeds of approximately $5 million from the offering, before deducting the underwriting discount and estimated offering expenses. The offering is expected to close on or about March 26, 2020, subject to customary closing conditions.

Laidlaw & Company (UK) Ltd. is acting as sole book-running manager for the offering. The Benchmark Company, LLC is serving as Qualified Independent Underwriter for the offering. Roth Capital Partners is acting as a financial advisor to the Company.

Hoth intends to use the net proceeds from the offering for general corporate purposes, including the development of products to prevent the COVID-19 virus, working capital, sales and marketing activities, and general and administrative matters.

You May Also Be Interested In

• ESS Tech closes $3.2M stock offering at $0.50 per share
• ESS Tech launches $3.2M stock offering at $0.50 per share
• Oruka Therapeutics (ORKA) files $1B mixed shelf